Contingent value rights

In corporate finance, Contingent Value Rights (CVR) are rights granted by an acquirer to a company’s shareholders, [1] facilitating the transaction where some uncertainty is inherent. CVRs may be separately tradeable securities; [2] they are occasionally acquired (or shorted) by specialized hedge funds. [3]

## Forms

[edit]

These rights typically take either of two forms:[4] (1) Event-driven CVRs compensate the owners for yet to eventuate positive developments in their business - hence protecting the acquirer against the valuation risk inherent in overpaying. (2) Price-protection CVRs are granted when payment is share based \- protecting the acquired company, by providing a hedge against downside price risk in the acquirer's equity. [5]

In the first case, CVRs are granted [2] in scenarios in which the acquiring company does not wish to pay for a product that might not work, has a limited market, or might need significant investment; whereas on the other side, the acquired company “wants to get full value for its assets”. The CVR then “helps bridge this negotiation”. Under these rights, shareholders will receive additional cash, securities, or benefits if a specific and named event occurs \- one where the value of the firm significantly increases \- within a specified timeframe. CVRs are common in the biotech and pharmaceutical industries (see Valuation (finance) § Valuation of intangible assets); they are also often granted to shareholders in companies facing significant, value accretive restructuring. For an example see Media General / Nexstar Media Group.

In the second case, protection against price risk is facilitated by specifying that payment will be made at an averaged, as opposed to final, share price; a floor may also be set. [6]

## Valuation

[edit]

Under both, the CVR is in function, a form of option. [7]

The first case: analogous to a call option, the payout to the CVR holder will be triggered by the event occurring, and will be zero otherwise. To determine the value of these rights, analysts will apply a modified option pricing model based on the probability of the event, the time horizon specified, and the corresponding payout rules; see Contingent claim valuation, Real options valuation, and Mergers and acquisitions § Business valuation. [8]

The second: the CVR takes the form of a modified Asian option.[5]

## See also

[edit]

* Strip financing
* Hold-up problem
* Earnout

## References

[edit]

1. ^ Investopedia (2020). Contingent Value Right (CVR)
2. ^ a b Motley Fool (2018). What Is a Contingent Value Right?
3. ^ See for example this prospectus as filed with the SEC.
4. ^ Thomson Reuters (2019). Contingent Value Rights (CVRs), Practical Law series
5. ^ a b Sris Chatterjee (2003). Contingent Value Rights in Acquisitions: Theory and Empirical Evidence, EFA 2003 Annual Conference Paper No. 897
6. ^ SEC (2006). Questions and Answers For Contingent Value Rights Holders
7. ^ Jan W Dash (2004). Quantitative Finance and Risk Management: A Physicist's Approach, World Scientific. ISBN 978-9812387127
8. ^ Aswath Damodaran (ND). Valuation: Approaches & Discounted Cash Flow Models

## External links

[edit]

* CVR on Investopedia
* CVR on Motley Fool
* Shadowy Shares: The Dark Side of Contingent Value Rights, Forbes.com (Michael Stocker, Iona Evan. 2011)

* v
* t
* e

Corporate finance and investment banking

Capital structure|

* Convertible debt
* Exchangeable debt
* Mezzanine debt
* Pari passu
* Preferred equity
* Second lien debt
* Senior debt
* Senior secured debt
* Shareholder loan
* Stock
* Subordinated debt
* Warrant

Transactions
(terms/conditions)|

| Equity offerings|

* At-the-market offering
* Book building
* Bookrunner
* Bought deal
* Bought out deal
* Corporate spin-off
* Direct public offering
* Equity carve-out
* Follow-on offering
* Greenshoe
* Reverse
* Initial public offering
* Pre-IPO
* Private placement
* Public offering
* Rights issue
* Seasoned equity offering
* Secondary market offering
* Underwriting

|

Mergers and
acquisitions|

* Buy side
* Contingent value rights
* Control premium
* Demerger
* Divestment
* Drag-along right
* Management due diligence
* Managerial entrenchment
* Mandatory offer
* Minority discount
* Pitch book
* Pre-emption right
* Proxy fight
* Post-merger integration
* Sell side
* Shareholder rights plan
* Special-purpose entity
* Special situation
* Squeeze-out
* Staggered board of directors
* Stock swap
* Supermajority amendment
* Synergy
* Tag-along right
* Takeover
* Reverse
* Tender offer

Leverage|

* Debt restructuring
* Debtor-in-possession financing
* Dividend recapitalization
* Financial sponsor
* Leveraged buyout
* Leveraged recapitalization
* High-yield debt
* Private equity
* Project finance

Valuation|

* Accretion/dilution analysis
* Adjusted present value
* Associate company
* Business valuation
* Conglomerate discount
* Cost of capital
* Weighted average
* Discounted cash flow
* Economic value added
* Enterprise value
* Fairness opinion
* Financial modeling
* Free cash flow
* Free cash flow to equity
* Market value added
* Minority interest
* Mismarking
* Modigliani–Miller theorem
* Net present value
* Pure play
* Real options
* Residual income
* Stock valuation
* Sum-of-the-parts analysis
* Tax shield
* Terminal value
* Valuation using multiples

* List of investment banks
* Outline of finance

*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template